In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Capricor Therapeutics, Inc.. Trade Record

NASDAQ:CAPR Capricor Therapeutics, Inc. stock gains 10.79% Exit Mar 25, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart CAPR Mar 13, 2019, priceSeries
About Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company's development stage drug candidates for cardiovascular diseases include CAP-1002 that is in Phase II clinical trials; and CAP-2003, which is in pre-clinical development for the treatment of certain cardiac and inflammatory conditions. The company was founded in 2005 and is headquartered in Beverly Hills, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
88.46
Entry Date
Mar 13, 2019
Entry Price
4.70
Sell Date
Mar 25, 2019
Sell Price
5.21
Net Gain
10.79%
Hold Time
8 Trading Days